Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sergey M. Kulikov"'
Autor:
Olga A. Aleshina, Kristina Zakurdaeva, Anastasia N. Vasileva, Sergey K. Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, Lev S. Butaev, Alena M. Sukhareva, Lubov V. Gavrilova, Inessa Yu. Toropova, Marina O. Popova, Aleksandr A. Siniaev, Aleksandr D. Kulagin, Kamil D. Kaplanov, Andrei A. Petrenko, Oksana I. Ochirova, Alina Karpova, Ekaterina Yu. Chelysheva, Anna G. Turkina, Margarita A. Gurianova, Liubov S. Al-Radi, Elena A. Gilyazitdinova, Elena K. Egorova, Yulia A. Chabaeva, Sergey M. Kulikov, Yulia V. Sveshnikova, Mikhail A. Kunst, Vasily Shuvaev, Anzhelika F. Rakhmani, Olga L. Panteleeva, Maria E. Grishunina, Olga S. Samoylova, Ekaterina Vorontsova, Daria V. Baryshnikova, Elena N. Parovichnikova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Autor:
Olga Senderova, Ekatarina Yu. Chelysheva, Maria V. Galayko, Alexandr S. Luchinin, Anna G. Turkina, Hunan Julhakyan, L V Gavrilova, Anton Kulikovsky, Valentina Pepeliaeva, Olga V. Lazareva, Sergey Meresiy, Olga Yu. Vinogradova, Galina I. Milutina, Lyudmila B. Avdeeva, Sergey M. Kulikov, Elena B. Dasheeva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e328-e335
Russia took part in the multicenter population-based study (Europe) and included 6.8% adult patients with newly diagnosed chronic myeloid leukemia (CML). The objective of this study was to analyze the mortality in the Russian cohort of patients with
Autor:
Olga Samoilova, Natalia Minaeva, Sergey M. Kulikov, Zalina Akhmerzaeva, Valeriy G. Savchenko, Andrey N. Sokolov, K D Kaplanov, Julia Chabaeva, Kliasova Ga, Sergey N. Bondarenko, Elena N. Parovichnikova, Olga A. Gavrilina, Vera V. Troitskaya, Larissa Kuzmina, Olga Yu Baranova
Publikováno v:
Acta Haematologica. 143:131-139
T-cell acute lymphoblastic leukemia (T-ALL) is a rare disease usually treated with intensive, high-dose consolidation chemotherapy followed by an allotransplant in a substantial number of patients. The data of the RALL-2009 study on 125 adult T-ALL p
Autor:
Sergey K. Kravchenko, Sergey M. Kulikov, Hunan Julhakyan, Andrey Sudarikov, Julia Chabaeva, Yana Mangasarova, Yana Kozhevnikova, Anna Yushkova, Natalya Risinskaya
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S385-S386
Context Molecular factors to determine the prognosis for primary mediastinal B-cell lymphoma (PMBCL) are not described yet. In this regard, the loss of heterozygosity (LOH) in STR loci and elevated microsatellite alteration at selected tetranucleotid
Autor:
Z V Konova, Valeriy G. Savchenko, V A Vasilyeva, Irina V. Galtseva, Hunan Julhakyan, Mikhail Drokov, Julia O. Davydova, Elena N. Parovichnikova, Sergey M. Kulikov, Larisa A. Kuzmina, Nikolay M. Kapranov
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S296
Context: The independent influence of pre-transplant MRD status on the results of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is now being widely reported. The genetic and immunophenotypic diversity of AML is a problem for monitori
Autor:
Yana Kozhevnikova, Olga Aleshina, Elena N. Parovichnikova, Valeriya Kovaleva, Hunan Julhakyan, Julia Chabaeva, Sergey M. Kulikov, Andrey Sudarikov, Anna Yushkova, Natalya Risinskaya
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S274
Context: Loss of heterozygosity (LOH) in some STR loci established for de novo-diagnosed ALL could be used as a prognostic factor for possible poor clinical outcomes. Objective: To identify LOH in the blast cells of patients with B- and T-ALL at diag
Autor:
Sergey M. Kulikov, Andrey N. Sokolov, A V Kokhno, T S Kaporskaya, Sergey A Makhinya, Yulia A. Chabaeva, Valery G. Savchenko, Larisa A. Kuzmina, Vera V. Troitskaya, Elena N. Parovichnikova, V A Lapin, Gennadiy M. Galstyan, G A Klyasova, Oleg A Latyshkevich, Olga A. Gavrilina
Publikováno v:
Leukemia Research. 104:106536
We report the data on 15 women who presented with Ph-negative acute lymphoblastic leukemia (ALL) between Jan 2009 until Dec 2016 and who were treated on the prospective multicenter RALL-2009 clinical trial. A comparison of their outcome was made with
Autor:
Julia Chabaeva, Valery G. Savchenko, Sergey K. Kravchenko, Valeriya Zheleznova, Yana Mangasarova, Elena E. Nikulina, Anna Yushkova, Andrey Sudarikov, Sergey M. Kulikov, Natalya Risinskaya
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S274-S275
Context: Loss of heterozygosity (LOH) in STR loci, elevated microsatellite alteration at selected tetranucleotides (EMAST) and instability of mononucleotide tandem repeats (MSI - microsatellite instability) are intrinsic features of diverse tumor cel
Autor:
Sergey M. Kulikov, Anastasia Bykova, Anna Kersilova, L. L. Vysotskaya, Olga Pospelova, Anna G. Turkina, Irina Martynkevich, Anatoly Golenkov, Andrey Sudarikov, Vasiliy Shuvaev, Galina Gusarova, Michael Fominykh, Margarita Gurianova, Oleg Shukhov, Anna Petrova, Nikolay Tsyba, A O Abdullaev, Hunan Julhakyan, Irina Nemchenko, Ekaterina Chelysheva, Polina Poshivay Agnia
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S239
Introduction Duration of treatment with tyrosine kinase inhibitors (TKI) is an important favorable prognostic factor for treatment-free remission (TFR) and deep molecular response (DMR) in patients (pts) with chronic myeloid leukemia (CML). Aim To an
Autor:
Olga A. Gavrilina, Elena N. Parovichnikova, Natalya Risinskaya, Sergey M. Kulikov, Valery G. Savchenko, Anna Yushkova, Julia Chabaeva, Andrey Sudarikov, Natalia Kostritsa
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S171
Context Loss of heterozygosity (LOH) was described for many malignancies including leukemia. Previously, we noted LOH at STR loci is especially frequent for relapsed ALL patients. LOH established for de novo-diagnosed ALL could be used as a prognosti